Form 4 for TMO Thermo Fisher Scientific
Accepted 2021-08-30 00:00:00 ET · period of report 2021-08-26 · accession 0001127602-21-024533 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-08-30 | 2021-08-26+ | TMO | Lagarde Michel | EVP | F - Tax | $551.32 | -859 | 16.9K | -5% | -$473.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-26 | F | D | 566 | $552.77 | 17,172.21 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-27 | F | D | 293 | $548.51 | 16,879.21 | D | — | — |